Gefitinib

Results: 146



#Item
41Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase

Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2014-09-11 08:36:45
42SMC  briefing note Scottish Medicines Consortium advice to NHSScotland

SMC briefing note Scottish Medicines Consortium advice to NHSScotland

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
43The HSP90 Inhibitor, AT13387, Displays Single Agent Activity in Erlotinib-Sensitive and -Resistant Models of EGFR-Activated NSCLC Keisha Hearn, Tomoko Smyth, Jon Lewis, Vanessa Martins, Neil Thompson, Mohammad Azab, John

The HSP90 Inhibitor, AT13387, Displays Single Agent Activity in Erlotinib-Sensitive and -Resistant Models of EGFR-Activated NSCLC Keisha Hearn, Tomoko Smyth, Jon Lewis, Vanessa Martins, Neil Thompson, Mohammad Azab, John

Add to Reading List

Source URL: astx.com

Language: English
44THE HSP90 INHIBITOR, AT13387, IS EFFECTIVE IN MUTANT EGFR AND ALK-POSITIVE NSCLC MODELS. Tomoko Smyth, Ana Rodriguez-Lopez, Rachel McMenamin, Victoria Lock, Jayne Curry, Brent Graham, John Lyons, Neil Thompson and Nicola

THE HSP90 INHIBITOR, AT13387, IS EFFECTIVE IN MUTANT EGFR AND ALK-POSITIVE NSCLC MODELS. Tomoko Smyth, Ana Rodriguez-Lopez, Rachel McMenamin, Victoria Lock, Jayne Curry, Brent Graham, John Lyons, Neil Thompson and Nicola

Add to Reading List

Source URL: astx.com

Language: English
45ALTG Clinical Trials Newsletter August 2010 President’s Message Special points of interest:

ALTG Clinical Trials Newsletter August 2010 President’s Message Special points of interest:

Add to Reading List

Source URL: www.altg.com.au

Language: English
46November 2012   Volume 16, Issue 9        The investment report that gives you the essenƟals to wisely invest in biotechnology securiƟes.

November 2012  Volume 16, Issue 9        The investment report that gives you the essenƟals to wisely invest in biotechnology securiƟes.

Add to Reading List

Source URL: www.biotechnav.com

Language: English - Date: 2013-01-16 17:13:33
47Lung Cancer Making Education Easy In this issue: HDREB for recurrent bronchial carcinoma

Lung Cancer Making Education Easy In this issue: HDREB for recurrent bronchial carcinoma

Add to Reading List

Source URL: www.altg.com.au

Language: English - Date: 2012-06-25 05:35:25
48AstraZeneca submission to the Post-Market Review of Authority Required PBS listings AstraZeneca welcomes the opportunity to contribute to the Post-Market Review of Authority Required Pharmaceutical Benefits Schedule (PBS

AstraZeneca submission to the Post-Market Review of Authority Required PBS listings AstraZeneca welcomes the opportunity to contribute to the Post-Market Review of Authority Required Pharmaceutical Benefits Schedule (PBS

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-04 00:10:33
49Public Summary Document Application No. 1161 – Assessment of EGFR mutation testing for the use of gefitinib in locally advanced or metastatic nonsquamous NSCLC Sponsor/Applicant/s:  AstraZeneca

Public Summary Document Application No. 1161 – Assessment of EGFR mutation testing for the use of gefitinib in locally advanced or metastatic nonsquamous NSCLC Sponsor/Applicant/s: AstraZeneca

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:57
50Microsoft Word - BRAFv10.docx

Microsoft Word - BRAFv10.docx

Add to Reading List

Source URL: www.austinpathology.org.au

Language: English - Date: 2015-01-28 18:03:44